Recap: Freeline Therapeutics Q2 Earnings

Freeline Therapeutics FRLN reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Freeline Therapeutics missed estimated earnings by 86.27%, reporting an EPS of $-0.95 versus an estimate of $-0.51.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 2.17% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Freeline Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.